日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review

代谢重编程作为调节自身免疫性疾病中Th17/Treg平衡的治疗靶点：一项综合综述

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1687755
Hu, Yuehong; Zhao, Qihan; Dai, Haoran; Wu, Yadi; Tang, Xinyue; Zhang, Naiqian; Jiang, Hanxue; Rui, Hongliang; Liu, Baoli
T细胞
自身免疫性疾病
代谢
Treg
代谢重编程
免疫/内分泌
发表日期：2025
文献求助 收藏

RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization

RNF20 通过 CDK9 依赖的 LSD1 稳定作用促进表观遗传免疫抑制。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2307150121
Dong, Bo; Wang, Xinzhao; Song, Xiang; Wang, Jianlin; Liu, Xia; Yu, Zhiyong; Zhou, Yongkun; Deng, Jiong; Wu, Yadi
CDK9
免疫/内分泌
表观遗传
LSD1
RNF20
发表日期：2024
文献求助 收藏

NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia

NF-κB抑制肺上皮细胞中视黄酸受体介导的GPRC5A转录激活，从而促进肿瘤形成

期刊:JCI Insight
影响因子:6.1
doi:10.1172/jci.insight.186558
Song, Hongyong; Ye, Xiaofeng; Liao, Yueling; Zhang, Siwei; Xu, Dongliang; Zhong, Shuangshuang; Jing, Bo; Wang, Tong; Sun, Beibei; Xu, Jianhua; Guo, Wenzheng; Li, Kaimi; Hu, Min; Kuang, Yanbin; Ling, Jing; Zhang, Tuo; Wu, Yadi; Du, Jing; Yao, Feng; Chin, Y Eugene; Wang, Qi; Zhou, Binhua P; Deng, Jiong
肿瘤
肿瘤免疫
上皮细胞
信号转导
NF-κB
细胞生物学
发表日期：2024
文献求助 收藏

Aldh2 deficiency plays a dual role in lung tumorigenesis and tumor progression

Aldh2 缺乏在肺肿瘤发生和肿瘤进展中发挥双重作用

期刊:Genes and Diseases
影响因子:
doi:10.1016/j.gendis.2023.04.030
Zhang, Hongjia; Sun, Xueqian; Li, Zhanming; Liu, Tingting; Zhang, Fang; Meng, Xinyu; Li, Kaimi; Xu, Jianhua; He, Wei; Jing, Bo; Wang, Tong; Ni, Na; Sun, Beibei; Yao, Feng; Wu, Yadi; Wang, Qi; Du, Jing; Chin, Eugene Y; Zhou, Binhua P; Jiang, Ping; Wang, Lishun; Deng, Jiong
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies

靶向卵巢癌中的受体酪氨酸激酶：基因组失调、抑制剂的临床评价及联合治疗的潜力

期刊:Molecular Therapy-Oncolytics
影响因子:5.3
doi:10.1016/j.omto.2023.02.006
Wei, Ying; Erfani, Sonia; Schweer, David; de Gouvea, Rafael; Qadir, Javeria; Shi, Junfeng; Cheng, Kai; Wu, Dabao; Craven, Rolf; Wu, Yadi; Olivier, Thibault; Baldwin, Lauren A; Zhou, Binhua; Zhou, Ying; Zhao, Weidong; Yang, Burton B; Ueland, Frederick R; Yang, Xiuwei H
信号转导
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination

FBXO24通过靶向LSD1进行泛素化来抑制乳腺癌的肿瘤发生

期刊:Molecular Cancer Research
影响因子:4.7
doi:10.1158/1541-7786.MCR-23-0169
Dong, Bo; Song, Xiang; Wang, Xinzhao; Dai, Tao; Wang, Jianlin; Yu, Zhiyong; Deng, Jiong; Evers, B Mark; Wu, Yadi
肿瘤
表观遗传
肿瘤免疫
泛素化
LSD1
乳腺癌
发表日期：2023
文献求助 收藏

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

社论：靶向癌细胞和宿主代谢以克服耐药性：临床前和临床研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1154661
Wang, Lishun; Xu, Hanchen; Wu, Yadi
细胞生物学
肿瘤
肿瘤免疫
代谢
发表日期：2023
文献求助 收藏

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway

EBF1通过监测HIF1α通路促进三阴性乳腺癌的进展。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2119518119
Qiu, Zhaoping; Guo, Weijie; Dong, Bo; Wang, Yu; Deng, Pan; Wang, Chi; Liu, Jinpeng; Zhang, Qing; Grosschedl, Rudolf; Yu, Zhiyong; Deng, Jiong; Wu, Yadi
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer

利用表观遗传药物治疗癌症中的上皮-间质转化

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2020.596239
Dong, Bo; Qiu, Zhaoping; Wu, Yadi
肿瘤
表观遗传
肿瘤免疫
发表日期：2020
文献求助 收藏

Ubiquitin Regulation: The Histone Modifying Enzyme's Story

泛素调控：组蛋白修饰酶的故事

期刊:Cells
影响因子:5.2
doi:10.3390/cells7090118
Wang, Jianlin; Qiu, Zhaoping; Wu, Yadi
信号转导
组蛋白修饰
表观遗传
发表日期：2018
文献求助 收藏